GO
Loading...

Bristol-Myers Squibb Co

More

  • Final Glance: Pharmaceuticals companies Thursday, 26 Mar 2015 | 6:07 PM ET

    Baxter International Inc. fell$. 12 or. 2 percent, to $68.02. Bristol-Myers Squibb Co. rose$. 30 or. 5 percent, to $65.00. Eli Lilly& Co. fell$. 92 or 1.2 percent, to $73.44.

  • Midday Glance: Pharmaceuticals companies Thursday, 26 Mar 2015 | 2:20 PM ET

    Baxter International Inc. rose$. 11 or. 2 percent, to $68.25. Bristol-Myers Squibb Co. rose$. 48 or. 7 percent, to $65.18. Eli Lilly& Co. fell$. 47 or. 6 percent, to $73.89.

  • Early Glance: Pharmaceuticals companies Thursday, 26 Mar 2015 | 10:34 AM ET

    Baxter International Inc. rose$. 04 or. 1 percent, to $68.18. Bristol-Myers Squibb Co. fell$. 08 or. 1 percent, to $64.62. Eli Lilly& Co. fell$. 61 or. 8 percent, to $73.75.

  • Final Glance: Pharmaceuticals companies Wednesday, 25 Mar 2015 | 6:03 PM ET

    Baxter International Inc. fell$. 36 or. 5 percent, to $68.14. Bristol-Myers Squibb Co. fell$. 99 or 1.5 percent, to $64.70. Eli Lilly& Co. fell $1.20 or 1.6 percent, to $74.36.

  • Midday Glance: Pharmaceuticals companies Wednesday, 25 Mar 2015 | 1:43 PM ET

    Baxter International Inc. fell$. 15 or. 2 percent, to $68.35. Bristol-Myers Squibb Co. fell$. 47 or. 7 percent, to $65.22. Eli Lilly& Co. fell$. 87 or 1.2 percent, to $74.69.

  • Early Glance: Pharmaceuticals companies Wednesday, 25 Mar 2015 | 11:55 AM ET

    Baxter International Inc. rose$. 03 or percent, to $68.53. Bristol-Myers Squibb Co. fell$. 14 or. 2 percent, to $65.55. Eli Lilly& Co. fell$. 29 or. 4 percent, to $75.27.

  • Science, patients driving rare disease drug research surge Wednesday, 25 Mar 2015 | 10:38 AM ET

    TRENTON, N.J.— The global pharmaceutical industry is pouring billions of dollars into developing treatments for rare diseases, which once drew little interest from major drugmakers but now point the way toward a new era of innovative therapies and big profits. The investments come as researchers harness recent scientific advances, including the mapping of...

  • Final Glance: Pharmaceuticals companies Tuesday, 24 Mar 2015 | 8:17 PM ET

    Baxter International Inc. fell$. 34 or. 5 percent, to $68.50. Bristol-Myers Squibb Co. fell $1.89 or 2.8 percent, to $65.69. Eli Lilly& Co. fell$. 80 or 1.0 percent, to $75.56.

  • Hottest dividend stocks of 2015 Tuesday, 24 Mar 2015 | 2:58 PM ET
    A trader works on the floor of the New York Stock Exchange.

    CNBC screened the large cap S&P 500 index to see where the hottest parts of the dividend stock market have been.

  • Midday Glance: Pharmaceuticals companies Tuesday, 24 Mar 2015 | 1:19 PM ET

    Baxter International Inc. fell$. 33 or. 5 percent, to $68.51. Bristol-Myers Squibb Co. fell $1.45 or 2.1 percent, to $66.13. Hospira fell$. 03 or percent, to $87.85.

  • Early Glance: Pharmaceuticals companies Tuesday, 24 Mar 2015 | 10:22 AM ET

    Baxter International Inc. fell$. 14 or. 2 percent, to $68.70. Bristol-Myers Squibb Co. fell$. 90 or 1.3 percent, to $66.68. Eli Lilly& Co. rose$. 14 or. 2 percent, to $76.50.

  • March 24- Merck& Co Inc said on Tuesday that it would stop a large study of its Keytruda melanoma treatment early because an independent monitoring committee determined the drug succeeded in its goal of prolonging survival in previously untreated patients at advanced stage of the disease. The medicine, a PD-1 inhibitor that works by taking the brakes off the...

  • March 24- Bristol-Myers Squibb said on Tuesday it had agreed to acquire rights to a Novo Nordisk immune system research program, which the Danish company is divesting as it focuses further on diabetes care. The project aims to modulate the innate immune system as a therapy for autoimmune diseases and the U.S. drugmaker said it fitted with its long-standing...

  • Final Glance: Pharmaceuticals companies Monday, 23 Mar 2015 | 6:03 PM ET

    Baxter International Inc. rose$. 66 or 1.0 percent, to $68.84. Eli Lilly& Co. rose$. 24 or. 3 percent, to $76.36. Hospira rose$. 24 or. 3 percent, to $87.88.

  • Midday Glance: Pharmaceuticals companies Monday, 23 Mar 2015 | 1:32 PM ET

    Baxter International Inc. rose$. 85 or 1.2 percent, to $69.03. Bristol-Myers Squibb Co. rose$. 22 or. 3 percent, to $67.98. Eli Lilly& Co. rose $1.04 or 1.4 percent, to $77.16.

  • Early Glance: Pharmaceuticals companies Monday, 23 Mar 2015 | 10:12 AM ET

    Baxter International Inc. rose$. 50 or. 7 percent, to $68.68. Bristol-Myers Squibb Co. rose$. 14 or. 2 percent, to $67.90. Eli Lilly& Co. rose$. 39 or. 5 percent, to $76.51.

  • *Up from three potential $1 billion- plus drugs in 2014. LONDON, March 23- Bristol-Myers Squibb, Sanofi and Novartis have the three top new drugs set to reach the market in 2015, among 11 products each with $1 billion- plus sales potential, according to a Thomson Reuters analysis. In total, 11 of the many new drugs set for launch in 2015 are expected to generate $1 billion-...

  • *Up from three potential $1 billion- plus drugs in 2014. LONDON, March 23- Bristol-Myers Squibb, Sanofi and Novartis have the three top new drugs set to reach the market in 2015, among 11 products each with $1 billion- plus sales potential, according to a Thomson Reuters analysis. In total, 11 of the many new drugs set for launch in 2015 are expected to generate $1 billion-...

  • Final Glance: Pharmaceuticals companies Friday, 20 Mar 2015 | 8:00 PM ET

    Baxter International Inc. rose$. 20 or. 3 percent, to $68.18. Bristol-Myers Squibb Co. fell$. 56 or. 8 percent, to $67.76. Eli Lilly& Co. rose $1.90 or 2.6 percent, to $76.12.

  • Midday Glance: Pharmaceuticals companies Friday, 20 Mar 2015 | 1:25 PM ET

    Baxter International Inc. fell$. 03 or percent, to $67.95. Bristol-Myers Squibb Co. rose$. 11 or. 2 percent, to $68.43. Eli Lilly& Co. rose $1.35 or 1.8 percent, to $75.57.